Zafrens

Zafrens is a biotech company revolutionizing drug discovery with its ultra-high-throughput platform, Z-Screen. This platform allows for the simultaneous creation and testing of hundreds of thousands of potential medicines, dramatically reducing time and cost while providing deeper insights into drug efficacy and safety. The company collaborates with leading pharmaceutical firms to accelerate breakthroughs in various disease areas.

Funding Round: Series A

Funding Amount: $31M

Date: 04-Feb-2025

Investors: imec.xpand, Prime Movers Lab, Kofa Healthcare, Global Brain

Markets: Biotech, Drug Discovery, Chemical Engineering, Life Science

HQ: San Diego, California, United States

Founded: 2021

Website: https://www.zafrens.com/

LinkedIn: https://www.linkedin.com/company/zafrens

Twitter: https://twitter.com/Zafrensbio

Instagram:

Facebook: